Molecular dynamic simulations of a hexagonal liquid crystalline phase to study drug partitioning and release mechanisms

18 March 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Liquid crystalline nanoparticles (LCNPs), such as hexosomes (HII), can enhance lipid nanoparticle-mediated drug delivery by improving drug absorption, solubility, and chemical stability. Additionally, LCNPs can be tailored to optimize their function in specific biological environments by incorporating non-external-linker lipids into the HII system lipid composition. In this study, we constructed an HII model system composed of a 90:10 phytantriol:farnesol ratio and performed all-atom molecular dynamics simulations. The simulations demonstrated that the model remained stable across various water-to-lipid ratios, and the impact of the water-to-lipid ratio on the HII structural properties was consistent with previous experimental observations. We then used this model to investigate the localization and interactions of two drug molecules: vancomycin and clarithromycin. The results show that the highly lipophilic clarithromycin predominantly associates with the lipid phase, whereas vancomycin, due to its combination of hydrophobic and hydrophilic residues, tends to localize at the water-lipid interface, interacting with both phases. We also constructed an HII system with repeating HII units enclosed within Pluronic F127 polymers. Simulations revealed that the F127 polymers interact with the lipid phases at the HII interface region, facilitating excess water permeation into the HII phase system. To investigate the initial surface release mechanism of the drug molecules, we performed umbrella sampling (US) simulations. The energy profiles from the umbrella sampling indicate that polymer-lipid-water interactions at the HII interface reduce the energy barrier for drug release, making the release of vancomycin easier compared to clarithromycin. Our in vitro release study further confirmed that vancomycin exhibited higher release compared to clarithromycin. Overall, the model developed in this study provided important molecular-level insights into drug loading, partitioning, and release kinetics from the HII phase system, enabling the design of effective drug delivery formulations.

Keywords

hexosome
non-lamellar
liquid crystal nanoparticle
antibiotics
vancomycin
clarithromycin
molecular dynamics simulation
drug partitioning
drug release mechanism

Supplementary materials

Title
Description
Actions
Title
Supporting information: Molecular dynamic simulations of a hexagonal liquid crystalline phase to study drug partitioning and release mechanisms
Description
Descriptions regarding the Umbrella sampling simulations for the logP calculation of Clarithromycin and Vancomycin. Table 1: Description of the simulated systems Supplementary figures mentioned in the main manuscript.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.